|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Nephrology and Hypertension and Center for Hypertension and Renal Disease Research, Georgetown University Medical Center, Washington, DC, USA
* To whom correspondence should be addressed. E-mail: wilcoxch{at}georgetown.edu.
A TP receptor mimetic causes salt-sensitive hypertension and renal afferent arteriolar vasoconstriction. TP-R mediate effects of Ang II on renal vascular resistance and drinking. Therefore, we investigated the hypothesis that TxA2 synthase (TxA2-S) and/or TP-R expression is regulated by salt and/or Ang II. Methods: Rats (n=6) received high salt (HS) or low salt (LS) diets. Additional HS received Ang II and additional HS and LS received the AT1 receptor (AT1-R) antagonist, losartan. Results: Excretion of TxB2 by conscious rats was increased by HS, compared to LS (LS, 48 ± 5 vs. 126 ± 10 pmol.24h-1; p<0.01). The mRNA abundance for TP-R (relative to
-actin) in kidney cortex was enhanced 30% by HS (p<0.001) and was reduced 30% by Ang II (p<0.001). However, during losartan, the effects of salt were reversed; mRNA more than doubled during LS (p<0.001). Likewise, the mRNA abundance for TP-R in the brain stem was reduced by 50% by Ang II (p<0.001) and, during losartan, was was almost doubled by LS (p<0.001). The mRNA abundance for TxA2-S in the kidney cortex also was increased many fold by HS (p<0.001). In contrast, the mRNA for TxA2-S in the brain was unaffected by salt. Ang II did not affect TxA2-S at either site. During losartan, TxA2-S increased modestly with LS in the brain stem. Conclusions: mRNA for TP-R in kidney cortex and brain stem are suppressed by Ang II acting on AT1-R. In the absence of AT1-R, expression of TP-R at both sites is enhanced by LS. In contrast, Ang II does not affect the mRNA abundance for TxA2-S. Expression of TxA2-S is enhanced by HS in the kidney cortex, but by LS in the brain stem only during losartan. Thus TP-R is strongly dependent on Ang II acting on AT1-R, whereas TxA2-S is regulated differentially in the kidney cortex and brain stem by salt intake.
This article has been cited by other articles:
![]() |
M. Araujo and W. J. Welch Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide Am J Physiol Renal Physiol, April 1, 2009; 296(4): F790 - F794. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sebekova, T. Eifert, A. Klassen, A. Heidland, and K. Amann Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes Diabetes, April 1, 2007; 56(4): 968 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qi, H. Cai, J. D. Morrow, and M. D. Breyer Differentiation of Cyclooxygenase 1- and 2-Derived Prostanoids in Mouse Kidney and Aorta Hypertension, August 1, 2006; 48(2): 323 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Welch Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NOS, and salt intake Am J Physiol Renal Physiol, April 1, 2005; 288(4): F757 - F762. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, T. Chabrashvili, and C. S. Wilcox Enhanced Contractility of Renal Afferent Arterioles From Angiotensin-Infused Rabbits: Roles of Oxidative Stress, Thromboxane Prostanoid Receptors, and Endothelium Circ. Res., June 11, 2004; 94(11): 1436 - 1442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |